IL6 and Insulin resistance: Specifically in cardiometabolic settings, chronically elevated IL-6 has been associated with central adiposity, insulin resistance, endothelial dysfunction, and increased cardiovascular risk, reflecting sustained activation of adipose and vascular compartments (Tylutka et al., 2024).